EUVIMEDEUVIMED entdecken
Open Access

Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy

Alison K Yoder iD, Ahsan S Farooqi, Cort Wernz, Aparna Subramaniam, Vinod Ravi, Ryan Goepfert iD, Erich M Sturgis, Devarati Mitra, Andrew J Bishop, B Ashleigh Guadagnolo

Head & Neck · 2023

DOI: 10.1002/hed.27418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2023. Verfasst von Alison K Yoder und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Hemangiosarcoma, Skin Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We investigated outcomes and prognostic factors for patients treated for cutaneous angiosarcoma (CA).

Methods

We conducted a retrospective review of patients treated for CA of the face and scalp from 1962 to 2019. All received definitive treatment with surgery, radiation (RT), or a combination (S‐XRT). The Kaplan–Meier method was used to estimate outcomes. Multivariable analyses were conducted using the Cox proportional hazards model.

Results

For the 143 patients evaluated median follow‐up was 33 months. Five‐year LC was 51% and worse in patients with tumors >5 cm, multifocal tumors, those treated pre‐2000, and with single modality therapy (SMT). These remained associated with worse LC on multivariable analysis. The 5‐year disease‐specific survival (DSS) for the cohort was 56%. Tumor size >5 cm, non‐scalp primary site, treatment pre‐2000, and SMT were associated with worse DSS.

Conclusion

Large or multifocal tumors are negative prognostic factors in patients with head and neck CA. S‐XRT improved outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemangiosarcomaSkin NeoplasmsHead and Neck NeoplasmsHumansRetrospective StudiesProportional Hazards ModelsCombined Modality TherapyPrognosis

Stichwörter der Autor:innen

angiosarcomaradiationsurgery

Autor:innen und Institutionen

  • Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Baylor College of Medicine, Houston, Texas, USA.
  • Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Alison K Yoder, Ryan Goepfert

Förderung

  • NCATS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Yoder, A. K., Farooqi, A. S., Wernz, C., Subramaniam, A., Ravi, V., Goepfert, R., Sturgis, E. M., Mitra, D., Bishop, A. J., & Guadagnolo, B. A. (2023). Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy. Head & Neck. https://doi.org/10.1002/hed.27418

Vancouver

Yoder AK, Farooqi AS, Wernz C, Subramaniam A, Ravi V, Goepfert R, et al. Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy. Head & Neck. 2023. doi:10.1002/hed.27418

BibTeX
@article{Yoder2023,
  author = {Yoder, Alison K and Farooqi, Ahsan S and Wernz, Cort and Subramaniam, Aparna and Ravi, Vinod and Goepfert, Ryan and Sturgis, Erich M and Mitra, Devarati and Bishop, Andrew J and Guadagnolo, B Ashleigh},
  title = {Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy},
  journal = {Head & Neck},
  year = {2023},
  doi = {10.1002/hed.27418}
}
Kostenlos starten →